Author(s): Carolina Cuéllar-García, Mattias Mattsson, Panagiotis Baliakas, Lydia Scarfo, Eva Puy Vicente, Paolo Ghia, Richard Rosenquist, Carol Moreno Abstract: S 462 Session topic: 6. Chronic lymphocytic leukemia and related disorders – Clinical Background: Chemoimmunotherapy (CIT) is the standard treatment for young and fit treatment-naive patients with CLL. The median progression-free-survival (PFS) in...
Pro zobrazení tohoto obsahu je třeba být přihlášen.